Cited by 2,514Global Cancer Incidence and ScreeningBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

The DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Antoni, Sebastien, Ferlay, Jacques, Soerjomataram, Isabelle, Znaor, Ariana, Jemal, Ahmedin, Bray, Freddie·2017·European Urology

DOI 10.1016/j.eururo.2016.06.010

Open this paper in CoChat — free account

Abstract

Context Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. Objective We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer. Evidence acquisition Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality). Evidence synthesis Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries. Conclusions The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time. Patient summary The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking.

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2016.06.010

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citation
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
The United Nations Development Programme
Oestreich, J. E. (2017) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,875
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, M. M., Andreas Böhle, E., Burger, M., Čapoun, O., Cohen, D. L., Compérat, É., Hernández, V., KAASINEN, E. S., Palou, J., Morgan Rouprêt, A., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.041 · Cited by 2,240
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Burger, M., Catto, J. W. F., Dalbagni, G. M., Grossman, H. B., Herr, H. W., Karakiewicz, P. I., Kassouf, W., Kiemeney, L. A. L. M., Vecchia, C. L., Shariat, S. F., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.07.033 · Cited by 2,212
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk
Steinmann, P., Keiser, J., Bos, R., Tanner, M., & Utzinger, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70521-7 · Cited by 2,146
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576
Estimating average annual per cent change in trend analysis
Clegg, L. X., Hankey, B. F., Tiwari, R. C., Feuer, E. J., & Edwards, B. K. (2009) · Statistics in Medicine · doi:10.1002/sim.3733 · Cited by 1,271
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Babjuk, M., Burger, M., Zigeuner, R., Shariat, S. F., van Rhijn, B. W. G., Compérat, E., Sylvester, R. J., Kaasinen, E., Böhle, A., Palou Redorta, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.003 · Cited by 1,174

Show all 55 references

Research works printed but not linked: 1

Loader C. Smoothing: Local Regression Techniques Web site. http://hdl.handle.net/10419/22186.

Sorted by citations

Items 601–700 of 1,000

Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer
Elsawy, A. A., Awadalla, A., El‐Sayed, A., Abdullateef, M., & Abol‐Enein, H. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.07.013 · Cited by 24
Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies
Carvalho, S., Abreu, C. M., Ferreira, D., Lima, L., Ferreira, J. A., Santos, L. L., Ribeiro, R. J. T., Grenha, V., Martínez‐Fernández, M., Dueñas, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01774 · Cited by 24
The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern
Wang, P., Zang, S., Li, G., Qu, W., Li, S., Qiao, Q., & Jiang, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.3560 · Cited by 24
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
Quhal, F., Pradère, B., Laukhtina, E., Motlagh, R. S., Mostafaei, H., Mori, K., Schuettfort, V. M., Karakiewicz, P. I., Morgan Rouprêt, A., Enikeev, D. V., et al. (2021) · World Journal of Urology · doi:10.1007/s00345-020-03586-1 · Cited by 24
MiR ‐186‐5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A /B
Zhang, Q.-J., Hao, L., Shen, Z., Wang, F., & Han, C. (2021) · Environmental Toxicology · doi:10.1002/tox.23331 · Cited by 24
circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis
Chen, L., Li, W., Li, Z., Song, Y., Zhao, J., Chen, Z., Kazobinka, G., Li, L., Xing, Y., & Hou, T. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.032 · Cited by 22
Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer
Gao, L., Ren, R., Shen, J., Hou, J., Ning, J., Feng, Y., Wang, M., Wu, L., Sun, Y., Wang, H., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10102-8 · Cited by 24
State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer
Kong, C., Zhang, S., Lei, Q., & Wu, S. (2022) · Biosensors · doi:10.3390/bios12100796 · Cited by 24
Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
Monteiro‐Reis, S., Miranda‐Gonçalves, V., Guimarães‐Teixeira, C., Martins‐Lima, C., Lobo, J., Montezuma, D., Dias, P. C., Neyret‐Kahn, H., Bernard‐Pierrot, I., Henrique, R., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.77181 · Cited by 24
CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer
Chen, W., Gong, M., Zhou, D., Zhang, L., Kong, J., Jiang, F., Feng, S., & Yuan, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1019749 · Cited by 24
Echinatin inhibits tumor growth and synergizes with chemotherapeutic agents against human bladder cancer cells by activating p38 and suppressing Wnt/β-catenin pathways
Wang, X., Luo, L., Xu, J., Lu, Q., Xia, H., Huang, Y., Zhang, L., Xie, L., Jiwa, H., Liang, S., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.031 · Cited by 24
MTHFD2 promotes PD‐L1 expression via activation of the JAK / STAT signalling pathway in bladder cancer
Li, L., Zhang, Y., Hu, W., Zou, F., Ning, J., Rao, T., Ruan, Y., Yu, W., & Fan, C. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17863 · Cited by 23
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
Sikic, D., Breyer, J., Hartmann, A., Burger, M., Erben, P., Denzinger, S., Eckstein, M., Stöhr, R., Wach, S., Wullich, B., et al. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.013 · Cited by 24
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma
Breyer, J., Wirtz, R. M., Erben, P., Worst, T. S., Stoehr, R., Eckstein, M., Bertz, S., Sikic, D., Denzinger, S., Burger, M., et al. (2018) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2018.01.009 · Cited by 24
Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis
Shi, H., Han, Y. K., Joaquim Bellmunt, B., Leow, J. J. J., Chen, X., Guo, C., Yang, H., & Zhang, X. (2018) · Quality of Life Research · doi:10.1007/s11136-018-1902-8 · Cited by 24
A pictorial review of bladder cancer nodal metastases
Shankar, P. R., Barkmeier, D. T., Hadjiiski, L. M., & Cohan, R. H. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2018.08.25 · Cited by 24
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer
Avgeris, M., Tsilimantou, A., Levis, P. K., Rampias, T. N., Papadimitriou, M., Panoutsopoulou, K., STRAVODIMOS, K. G., & Scorilas, A. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz045 · Cited by 24
YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo‐/radio‐resistance by suppressing caspase‐mediated apoptosis
Yu, C., Li, C., Chen, I., Lai, M., Lin, Z., Korla, P. K., Chai, C., Ko, G., Chen, C., Hwang, T., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5274 · Cited by 24
A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer
Gong, P., Xu, R., Zhuang, Q., & He, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110059 · Cited by 24
Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma
Oikawa, M., Hatakeyama, S., Yoneyma, T., Tobisawa, Y., Narita, T., Yamamoto, H., Hashimoto, Y., Koie, T., Narita, S., Sasaki, A., et al. (2016) · European Urology Focus · doi:10.1016/j.euf.2016.11.004 · Cited by 24
A Simple Three-Dimensional In Vitro Culture Mimicking the In Vivo-Like Cell Behavior of Bladder Patient-Derived Xenograft Models
do Amaral, R. L. F., Zimmermann, M., Ma, A., Zhang, H., Swiech, K., & Pan, C.-X. (2020) · Cancers · doi:10.3390/cancers12051304 · Cited by 23
Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects
Song, Y., Yang, Y., Liu, L., & Liu, X. (2019) · Gene · doi:10.1016/j.gene.2019.02.070 · Cited by 23
Current Status of Functional Studies on Circular RNAs in Bladder Cancer and their Potential Role as Diagnostic and Prognostic Biomarkers: A Review
Liang, C., Yang, Q., Hu, C., Yu, Q., Hao, S., & Li, D. (2019) · Medical Science Monitor · doi:10.12659/msm.916697 · Cited by 23
Targeting the Immune system and Epigenetic Landscape of Urological Tumors
Lobo, J., Jerónimo, C., & Henrique, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030829 · Cited by 23
LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143
Qiao, Z., Dai, H., Zhang, Y., Li, Q., Zhao, M., & Yue, T. (2020) · Cancer Management and Research · doi:10.2147/cmar.s223172 · Cited by 23
SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition
Chen, W., Jiang, T., Mao, H., Gao, R., Zhang, H., He, Y., Liu, C., & Chen, Q. (2020) · Human Cell · doi:10.1007/s13577-020-00343-9 · Cited by 23
Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment
Wu, Q., Wong, J. P. C., & Kwok, H. F. (2020) · Cells · doi:10.3390/cells9051213 · Cited by 24
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
Wang, L., Zhang, Q., Wu, P., Xiang, W., Xie, D., Wang, N., Deng, M., Cao, K., Zeng, H., Xu, Z., et al. (2020) · Cancer Science · doi:10.1111/cas.14502 · Cited by 22
Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes
Reed, O., Jubber, I., Griffin, J., Noon, A. P., Goodwin, L., Hussain, S. A., Cumberbatch, M. G. K., & Catto, J. W. F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239338 · Cited by 23
Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling
Tang, C., Ma, J., Liu, X., & Liu, Z. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01973-4 · Cited by 22
Roles and regulatory mechanisms of miR‑30b in cancer, cardiovascular disease, and metabolic disorders (Review)
Zhang, Q. H., Liu, S., Zhang, J., Ma, X., Dong, M., Sun, B., & Xin, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9475 · Cited by 23
Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
Sun, X., Chen, Q., Zhang, L., Chen, J., & Zhang, X. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021313 · Cited by 22
APE1 and SSRP1 is overexpressed in muscle invasive bladder cancer and associated with poor survival
Song, H., Zeng, J., Lele, S. M., LaGrange, C. A., & Bhakat, K. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06756 · Cited by 23
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer
Ma, T., Wang, X., Meng, L., Liu, X., Wang, J., Zhang, W. Y., Tian, Z., & Zhang, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08981-4 · Cited by 23
PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth
Bhattacharjee, S., Sullivan, M. J., Wynn, R. R., Demagall, A., Hendrix, A. S., Sindhwani, P., Petros, F. G., & Nadiminty, N. (2022) · BMC Cancer · doi:10.1186/s12885-022-09376-9 · Cited by 23
circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5
Lu, Q., Yin, H., Deng, Y., Chen, W., Diao, W., Ding, M., Cao, W., Fu, Y. S., Mo, W., Chen, X., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01037-x · Cited by 23
Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice
Cai, Q., Ling, J., Kong, L., Huang, Y. P., Lin, Y. Y., Wen, Z. H., Li, M., Guo, Y., & Wang, H. J. (2022) · Radiology · doi:10.1148/radiol.220028 · Cited by 23
Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study
Ren, X. Z., Tian, Y., Wang, Z., Wang, J., Li, X., Yin, Y., Chen, R., Zhan, Y., & Zeng, X. (2022) · BMC Urology · doi:10.1186/s12894-022-01083-8 · Cited by 23
Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancer
Xiao, Y., Xu, D., Jiang, C., Huili, Y., Nie, S., Zhu, H., Fan, G., & Guan, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1087246 · Cited by 23
The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model
Oliveira, P. A., Nóbrega, C., da Costa, R. M. G., & Arantes‐Rodrigues, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7234-0_13 · Cited by 23
YRNA expression in prostate cancer patients: diagnostic and prognostic implications
Tolkach, Y., Niehoff, E.-M., Stahl, A. F., Zhao, C., Kristiansen, G., Müller, S. C., & Ellinger, J. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2250-6 · Cited by 23
Modeling human bladder cancer
Goulet, C. R., Bolduc, S., & Pouliot, F. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2369-5 · Cited by 24
Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D
Qiang, Z., Zhou, Z., Peng, T., Jiang, P., Shi, N., Njoya, E. M., Azimova, B., Liu, W., Chen, W., Zhang, G., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0971-4 · Cited by 23
Assessment of the use of the Internet and social media among people with bladder cancer and their carers, and the quality of available patient‐centric online resources: a systematic review
Tariq, A., Khan, S. R., Vela, I., & Williams, E. D. (2019) · British Journal of Urology · doi:10.1111/bju.14720 · Cited by 23
Trends in socio-economic inequalities in bladder cancer incidence in Canada: 1992–2010
Densmore, R., Hajizadeh, M., & Hu, M. (2019) · Canadian Journal of Public Health · doi:10.17269/s41997-019-00227-y · Cited by 23
Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway
Gong, H. C., Chen, W., Mi, L., Wang, D., Zhao, Y., Yu, C., & Zhao, A. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1626449 · Cited by 23
Catalog of exogenous risk factors for bladder carcinogenesis
Jahrreiss, V., Pradère, B., Laukhtina, E., Mori, K., & Shariat, S. F. (2020) · Current Opinion in Urology · doi:10.1097/mou.0000000000000753 · Cited by 23
N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies
Song, Y., Qi, X., & Liu, X. (2020) · Gene · doi:10.1016/j.gene.2020.144924 · Cited by 23
LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis
Li, D.-B., Zhong, S., Zhu, Z., Jiang, X., Zhang, J., Gu, J., & Chen, F. (2020) · Pathobiology · doi:10.1159/000509957 · Cited by 23
Retracted
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
Ascierto, P. A., Daniele, B., Hammers, H. J., Hirsh, V., Kim, J. W., Licitra, L. F., Nanda, R., & Pignata, S. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1309-2 · Cited by 22
Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial
Wang, X.-Y., He, J., Juma, S., Kabole, F. M., Guo, J.-G., Dai, J., Li, W., & Yang, K. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007238 · Cited by 22
Identification of a potentially functional circRNA–miRNA–mRNA regulatory network for investigating pathogenesis and providing possible biomarkers of bladder cancer
Lü, Q., Yao, J., Yang, X. F., Han, J., Wang, J.-Z., Xu, K., Zhou, R., Yu, H., Lv, Q., & Gu, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1108-3 · Cited by 22
Beneficial effect of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy
Luo, J., Zhou, L., Lin, S., Yan, W., Huang, L., & Liang, S. (2020) · Clinics · doi:10.6061/clinics/2020/e1639 · Cited by 22
Gender Differences in Incidence, Diagnosis, Treatments, and Outcomes in Clinically Localized Bladder and Renal Cancer
Gul, Z., Liaw, C. W., & Mehrazin, R. (2020) · Urology · doi:10.1016/j.urology.2020.05.067 · Cited by 22
The role of long noncoding RNA SNHG7 in human cancers (Review)
Bian, Z., Ji, W., Xu, B., Huang, W., Jiao, J., Shao, J., & Zhang, X. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2115 · Cited by 22
1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression
Matheus, L. H. G., Dalmazzo, S. V., Brito, R. B. D. O., Pereira, L. A., de Almeida, R. J., Camacho, C. P., & Dellê, H. (2020) · BMC Cancer · doi:10.1186/s12885-020-07371-6 · Cited by 22
SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells
Kotolloshi, R., Hölzer, M., Gajda, M. R., Grimm, M., & Steinbach, D. (2021) · Cells · doi:10.3390/cells10010080 · Cited by 22
A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer
Zhang, C., Berndt‐Paetz, M., & Neuhaus, J. (2021) · Cancers · doi:10.3390/cancers13123089 · Cited by 22
Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial–Mesenchymal Transition
Zou, J., Huang, R., Chen, Y., Huang, X., Li, H., Liang, P., & Chen, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.2139/ssrn.3745779 · Cited by 22
Circular RNA circSETD3 hampers cell growth, migration, and stem cell properties in bladder cancer through sponging miR-641 to upregulate PTEN
Tian, Y., Gao, P., Dai, D., Chen, L., Chu, X., & Mei, X. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1954758 · Cited by 22
Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT/STAT3/NF-kB signaling
Dai, R., Jiang, Q., Zhou, Y. L., Lin, R., Lin, H., Zhang, Y., Zhang, J., & Gao, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02114-4 · Cited by 22
Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer
Zheng, X. F. S., Liu, Z., Zhong, J., Zhou, L., Chen, J., Zheng, L., Li, Z., Zhang, R., Pan, J., Wu, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02371-1 · Cited by 23
Urine and fecal microbiota in a canine model of bladder cancer and comparison of canine and human urine microbiota
Mrofchak, R., Madden, C. C., Evans, M. V., Kisseberth, W. C., Dhawan, D., Knapp, D. W., & Hale, V. L. (2022) · All Life · doi:10.1080/26895293.2022.2154858 · Cited by 22
Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade
Lv, J., Wu, Q., Li, K., Bai, K., Yu, H., Zhuang, J., Sun, H., Yang, H., Yang, X. F., & Lü, Q. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87182 · Cited by 22
Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
Lee, Y., Wang, C.-T., Huang, S. K., Wu, W., Huang, C., Li, C., Chan, T., Liang, P., Hsing, C., & Li, C. (2016) · Journal of Cancer · doi:10.7150/jca.16798 · Cited by 22
Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea
Kwon, W., Joung, J. Y., Lim, J., Oh, C., Jung, K., Kim, S. H., Seo, H. K., Park, W. S., Chung, J., Lee, K. H., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4530-3 · Cited by 22
FOXM 1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT 1 non‐muscle‐invasive bladder cancer
Breyer, J., Wirtz, R. M., Erben, P., Rinaldetti, S. L., Worst, T. S., Stoehr, R., Eckstein, M., Sikic, D., Denzinger, S., Burger, M., et al. (2018) · British Journal of Urology · doi:10.1111/bju.14525 · Cited by 22
Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer
Mansour, A. M., Rahim, M. A., Laymon, M. N., Elsherbeeny, M., Sultan, M., Shokeir, A. A., Mosbah, A., Abol‐Enein, H., Awadalla, A., Cho, E., et al. (2018) · BMC Urology · doi:10.1186/s12894-018-0413-9 · Cited by 22
Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells
Tsui, K.-H., Hou, C., Chang, K., Lin, Y., Feng, T., Chen, C.-C., Shin, Y.-S., & Juang, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040980 · Cited by 22
Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis
Oh, J. J., Byun, S., Jeong, C. W., Kwak, C. H., Kim, H. H., & Ku, J. H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00158 · Cited by 22
Development of a novel six‐long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma
Gao, X., Zhang, S., Chen, Y., Wen, X., Chen, M., Wang, S., & Zhang, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29285 · Cited by 22
Low‐resolution fiber‐optic Raman spectroscopy for bladder cancer diagnosis: A comparison study of varying laser power, integration time, and classification methods
Chen, H., Li, X., Broderick, N. G. R., & Xu, W. (2019) · Journal of Raman Spectroscopy · doi:10.1002/jrs.5783 · Cited by 22
Prognostic significance of red cell distribution width in bladder cancer
Ma, W., Mao, S., Bao, M., Wu, Y., Guo, Y., Liu, J., Wang, R., Cheng, L., Zhang, J., Zhang, W., et al. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2020.03.08 · Cited by 22
Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells
Miranda, M. A., Marcato, P. D., Mondal, A., Chowdhury, N., Gebeyehu, A., Surapaneni, S. K., Bentley, M. V. L. B., do Amaral, R. L. F., Pan, C.-X., & Singh, M. S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111460 · Cited by 22
UBAC2 promotes bladder cancer proliferation through BCRC-3/miRNA-182-5p/p27 axis
Gu, C., Zhao, K., Zhou, N., Liu, F., Xie, F., Yu, S., Feng, Y., Chen, L., Yang, J., Tian, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02935-7 · Cited by 22
Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway
Gao, X., Liu, J., Fan, D., Li, X., Fang, Z., Yan, K., & Fan, Y. (2021) · Oncology Reports · doi:10.3892/or.2021.8244 · Cited by 22
Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects
Song, Y., Hu, J., Chen, Q., Guo, J., Zou, Y., Zhang, W., Chen, X., Wang, H., & Huang, P. (2018) · Gene · doi:10.1016/j.gene.2018.09.005 · Cited by 21
DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
Tian, Z., Meng, L., Long, X., Diao, T., Hu, M., Wang, M., Liu, M., & Wang, J. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01345-1 · Cited by 21
TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells
Wang, G., Cao, R., Qian, K., Peng, T., Yuan, L., Chen, L., Cheng, S., Xiong, Y., Ju, L., Wang, X., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s257056 · Cited by 21
Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway
Xu, T., Rao, T., Yu, W.-M., Ning, J., Yu, X. Y., Zhu, S., Yang, K., Bai, T., & Fan, C. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4942 · Cited by 21
RETRACTED: Long Noncoding RNA SNHG1 Activates Autophagy and Promotes Cell Invasion in Bladder Cancer
Guo, C., Li, X., Xie, J., Liu, D., Geng, J., Ye, L., Yang, Y., Yao, X., & Luo, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.660551 · Cited by 21
Retracted
ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
Wang, Y., Wu, J., Luo, W., Zhang, H., Shi, G., Shen, Y., Zhu, Y., Ma, C., Dai, B., Ye, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03947-7 · Cited by 21
MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer
Yang, L., Sun, H., Guo, L.-Q., & Cao, H.-B. (2021) · Cancer Management and Research · doi:10.2147/cmar.s326732 · Cited by 21
Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)
Kobayashi, K., Matsuyama, H., Kawai, T., Ikeda, A., Miyake, M., Nishimoto, K., Matsushita, Y., Komura, K., Abe, T., Kume, H., et al. (2022) · International Journal of Urology · doi:10.1111/iju.14854 · Cited by 21
Urinary Bladder Cancer in Egypt: Are There Gender Differences in Its Histopathological Presentation?
Kyritsi, F., Loffredo, C. A., Zheng, Y., Philips, G. K., & Amr, S. (2018) · Advances in Urology · doi:10.1155/2018/3453808 · Cited by 21
The current status of robot-assisted cystectomy
Tyritzis, S. Ι., Collins, J., & Wiklund, P. N. (2018) · Indian Journal of Urology · doi:10.4103/iju.iju_355_17 · Cited by 21
Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC)
Datovo, J. C. F., Neto, W. A., Mendonça, G. B. D., Andrade, D. L., & Reis, L. O. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02697-8 · Cited by 21
Impact of sex difference on survival of bladder cancer: A population‐based registry data in Japan
Nakayama, M., Ito, Y., Hatano, K., Nakai, Y., Kakimoto, K., Miyashiro, I., & Nishimura, K. (2019) · International Journal of Urology · doi:10.1111/iju.13955 · Cited by 21
MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer
Wu, X., Chen, H., Zhang, G., Wu, J., Zhu, W., Gu, Y., & He, Y. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9903-5 · Cited by 21
Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas
Kvikstad, V., Mangrud, O. M., Gudlaugsson, E. G., Dalen, I., Espeland, H., Baak, J. P. A., & Janssen, E. A. M. (2019) · Diagnostic Pathology · doi:10.1186/s13000-019-0868-3 · Cited by 21
Immunotherapy and urothelial carcinoma: An overview and future prospectives
Pierantoni, F., Maruzzo, M., Gardi, M., Bezzon, E., Gardiman, M. P., Porreca, A., Basso, U., & Zagonel, V. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.08.005 · Cited by 21
The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma
Phạm, Q. T., Oue, N., Yamamoto, Y., SHIGEMATSU, Y., Sekino, Y., Sakamoto, N., Sentani, K., Uraoka, N., Tiwari, M., & Yasui, W. (2017) · Anticancer Research · doi:10.21873/anticanres.11637 · Cited by 21
Cancer-associated methylated lncRNAs in patients with bladder cancer.
Zhang, S., Cao, H., Ye, L., Wen, X., Wang, S., Zheng, W., Zhang, Y., Huang, D., Gao, Y., Liu, H., et al. (2019) · PubMed Central · Cited by 21
Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer
Chen, C., Huang, H., Zhao, Y., Liu, H., Luo, Y., Sylvester, R. J., Li, J. P., Lam, T. B. L., Lin, T., & Huang, J. (2019) · Journal of Cancer · doi:10.7150/jca.34527 · Cited by 21
Trends in cancer incidence in Uruguay:2002 - 2015
Garau, M., Musetti, C., Alonso, R., & Barrios, E. (2019) · Colombia medica · doi:10.25100/cm.v50i4.4212 · Cited by 20
Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada
Hird, A. E., Saskin, R., Liu, Y., Lee, Y., Ajib, K., Matta, R., Kodama, R. T., Carr, L. K., Kulkarni, G. S., Herschorn, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050728 · Cited by 22
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Eckstein, M., Jung, R., Weigelt, K., Sikic, D., Stöhr, R., Geppert, C. I., Agaimy, A., Lieb, V., Hartmann, A., Wullich, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35637-4 · Cited by 21
Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1
Arif, T., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2024) · Biomolecules · doi:10.3390/biom14101304 · Cited by 23
Urease-Driven Janus Nanomotors for Dynamic Enrichment and Multiplexed Detection of Bladder Cancer MicroRNAs in Urine
Zhou, H., Liu, Q., Chen, M., Xie, Y., Xu, W., Zhang, X., Jiang, C., Dou, P., Fang, Z., Wang, H., et al. (2025) · ACS Sensors · doi:10.1021/acssensors.4c02996 · Cited by 20
Bladder-sparing treatment in MIBC: where do we stand?
Murali-Krishnan, S., Pang, K. H., Greco, F., Fiori, C., Catto, J. W. F., Vavassori, V., & Esperto, F. (2019) · Minerva Urologica e Nefrologica · doi:10.23736/s0393-2249.19.03317-4 · Cited by 20

Authors: Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F.
Affiliations: Centre international de recherche sur le cancer (FR)
American Cancer Society (US)
Corresponding author: Bray, Freddie
ORCID: Ferlay, Jacques
Soerjomataram, Isabelle
Znaor, Ariana
Jemal, Ahmedin
Bray, Freddie
Venue: European Urology
Publisher: Elsevier BV
Published: 2017-01
Volume: 71
Issue: 1
Pages: 96-108
ISSN: 0302-2838 (ISSN-L)
DOI: 10.1016/j.eururo.2016.06.010
OpenAlex: W2473162054
Cited by: 2,514
References: 55
Citations by year: 2026: 79 · 2025: 165 · 2024: 248 · 2023: 244 · 2022: 314 · 2021: 414 · 2020: 400 · 2019: 306 · 2018: 225 · 2017: 102
FWCI: 21.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Urology (publishedVersion)
PubMed (publishedVersion)
Funders: World Health Organization
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
Keywords: bladder cancer, cancer incidence, cancer mortality, incidence trends, sex differences, smoking, Schistosoma haematobium, etiology, global cancer statistics
MeSH terms: Urinary Bladder Neoplasms, Female, Humans, Male, Registries, Risk Factors, Smoking, Global Health, Incidence, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks